发明人王建平,郑宇鹏,胡光. "Method for the Synthesis of Vonoprazan Fumarate Impurity 152" [P]. 中国发明专利, 专利号 CN 117740505 B, 授权公告日 2024-02-15.
发明人韩伟,孙丽萍,李文辉. "A Process for Preparing High-Purity Vonoprazan Fumarate Impurity 152" [P]. 中国发明专利, 专利号 CN 117465062 B, 授权公告日 2016-09-25.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,请询 C4X-1020110】富马酸伏诺拉生杂质152 in Pharmaceutical Formulations". Anal. Chem., 2020, 2355, 9194-9223.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,请询 C4X-1020110】富马酸伏诺拉生杂质152 as an Impurity". Biomed. Chromatogr., 2011, 576, 1883-1904.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Vonoprazan Fumarate Impurity 152 Using HRMS and NMR". J. Sep. Sci., 2019, 354, (2), 1305-1327.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 【停用,请询 C4X-1020110】富马酸伏诺拉生杂质152 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2025, 1763, (2), 3562-3573.